Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice

Diabetes

Volumn 54, Issue 3, 2005, Pages 778-784

  Liu, Xiaoli ^a   Wei, Jiao ^a   Peng, David H ^a   Layne, Matthew D ^a,b   Yet, Shaw Fang ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEME OXYGENASE 1; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ENZYME DEGRADATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE THROMBOSIS; HYPERGLYCEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORTALITY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; STREPTOZOCIN DIABETES; THROMBOGENESIS; UPREGULATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS;

EID: 14644400430     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.3.778     Document Type: Article

References (46)

1. Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 8:S23-S29, 1991
2. Ray NF, Thamer M, Taylor T, Fehrenbach SN, Ratner R: Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab 81:3671-3679, 1996
3. Rodrigues B, Cam MC, McNeill JH: Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 180:53-57, 1998
4. Jelesoff NE, Feinglos M, Granger CB, Califf RM: Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials. Coron Artery Dis 7:732-743, 1996
5. Savage MP, Krolewski AS, Kenien GG, Lebeis MP, Christlieb AR, Lewis SM: Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factor. Am J Cardiol 62:665-669, 1988
6. Woodfield SL, Lundergan CF, Reiner JS, Greenhouse SW, Thompson MA, Rohrbeck SC, Deychak Y, Simoons ML, Califf RM, Topol EJ, Ross AM: Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 28:1661-1669, 1996
7. Aronson D, Rayfield EJ, Chesebro JH: Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 126:296-306, 1997
8. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
9. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445, 1996
10. Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1-9, 1999
11. Choi AM, Alam J: Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15:9-19, 1996
12. Maines MD: The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997
13. Yet S-F, Perrella MA, Layne MD, Hsieh C-M, Maemura K, Kobzik L, Wiesel P, Christou H, Kourembanas S, Lee M-E: Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 103:R23-R29, 1999
14. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 4:1073-1077, 1998
15. Clark JE, Foresti R, Green CJ, Motterlini R: Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem J 348:615-619, 2000
16. Yet S-F, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee M-E, Perrella MA: Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89:168-173, 2001
17. Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet S-F, Pinsky DJ: Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7:598-604, 2001
18. Melo LG, Agrawal R, Zhang L, Rezvani M, Mangi AA, Ehsan A, Griese DP, Dell'Acqua G, Mann MJ, Oyama J, Yet S-F, Layne MD, Perrella MA, Dzau VJ: Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation 105:602-607, 2002
19. Yet S-F, Layne MD, Liu X, Chen Y-H, Ith B, Sibinga NES, Perrella MA: Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17:1759-1761, 2003
20. Pileggi A, Cattan P, Berney T, Molano RD, Vizzardelli C, Ricordi C, Bach FH, Inverardi L: HO-1 upregulation protects the pancreatic cell line βTC3 from cytokines and Fas-induced apoptosis. Transplant Proc 33:266-267, 2001
21. Tobiasch E, Gunther L, Bach FH: Heme oxygenase-1 protects pancreatic β cells from apoptosis caused by various stimuli. J Investig Med 49:566-571, 2001
22. Ribeiro MM, Klein D, Pileggi A, Molano RD, Fraker C, Ricordi C, Inverardi L, Pastori RL: Heme oxygenase-1 fused to a TAT peptide transduces and protects pancreatic β-cells. Biochem Biophys Res Commun 305:876-881, 2003
23. Abraham NG, Kushida T, McClung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, Wolin M: Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93:507-514, 2003
24. Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, Goodman AI, Wolin MS, Abraham NG: Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315:509-516, 2004
25. Jones SP, Girod WG, Granger DN, Palazzo AJ, Lefer DJ: Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol 277:H763-H769, 1999
26. Nishio Y, Kashiwagi A, Taki H, Shinozaki K, Maeno Y, Kojima H, Maegawa H, Haneda M, Hidaka H, Yasuda H, Horiike K, Kikkawa R: Altered activities of transcription factors and their related gene expression in cardiac tissues of diabetic rats. Diabetes 47:1318-1325, 1998
27. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R: Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol 278:H643-H651, 2000
28. 2 in human umbilical vein endothelial cells cultured in high glucose medium. Diabetologia 37:264-269, 1994
29. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
30. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ, Jr, Chow WS, Stern D, Schmidt AM: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031, 1998
31. Morita T, Kourembanas S: Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96:2676-2682, 1995
32. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM: Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269:H2147-H2154, 1995
33. Michael LH, Ballantyne CM, Zachariah JP, Gould KE, Pocius JS, Taffet GE, Hartley CJ, Pham TT, Daniel SL, Funk E, Entman ML: Myocardial infarction and remodeling in mice: effect of reperfusion. Am J Physiol 277:H660-H668, 1999
34. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, Witzum JL: Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits: Arteriosclerosis 10:336-349, 1990
35. Shi C, Lee W-S, Russell ME, Zhang D, Fletcher DL, Newell JB, Haber E: Hypercholesterolemia exacerbates transplant arteriosclerosis via increased neointimal smooth muscle cell accumulation: studies in apolipoprotein E knockout mice. Circulation 96:2722-2728, 1997
36. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
37. Entman ML, Youker K, Shoji T, Kukielka G, Shappell SB, Taylor AA, Smith CW: Neutrophil induced oxidative injury of cardiac myocytes: a compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90:1335-1345, 1992
38. Entman ML, Smith CW: Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res 28:1301-1311, 1994
39. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, Davis RJ, Flavell RA, Choi AM: Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428, 2000
40. Minamino T, Christou H, Hsieh C-M, Liu Y, Dhawan V, Abraham NG, Perrella MA, Mitsialis SA, Kourembanas S: Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci U S A 98:8798-8803, 2001
41. mox-1 constitutes an adaptive response to effect antioxidant cardioprotection: A study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 103:1695-1701, 2001
42. Ono K, Goto Y, Takagi S, Baba S, Tago N, Nonogi H, Iwai N: A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 173:315-319, 2004
43. Brune B, Ullrich V: Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32:497-504, 1987
44. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI: Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100:589-596, 1997
45. Peng L, Mundada L, Stomel JM, Liu JJ, Sun J, Yet S-F, Fay WP: Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antioxid Redox Signal 6:729-735, 2004
46. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP: Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166:4185-4194, 2001